21:25 GMT05 August 2021
Listen Live
    World
    Get short URL
    3260
    Subscribe

    MOSCOW (Sputnik) - Russia's Sputnik V vaccine against COVID-19 demonstrated 97.8% efficacy against coronavirus cases and 100% efficacy against severe cases during the vaccination campaign in the United Arab Emirates, the Russian Direct Investment Fund (RDIF) said on Tuesday.

    "RDIF announces the data of the UAE's Ministry of Health on the Russian Sputnik V coronavirus vaccine confirming its safety and high efficacy during the vaccination campaign. Efficacy among more than 81,000 subjects who had received both components of Sputnik V was 97.8%. The analysis is based on the data collected by 8 June 2021. The Russian vaccine was also fully (100%) effective against severe cases of COVID", the RDIF said in a press release.

    Vial labelled Sputnik V coronavirus disease (COVID-19) vaccine placed on displayed Sputnik V logo is seen in this illustration picture taken March 24, 2021.
    © REUTERS / DADO RUVIC
    Vial labelled "Sputnik V coronavirus disease (COVID-19) vaccine" placed on displayed Sputnik V logo is seen in this illustration picture taken March 24, 2021.

    No severe adverse events associated with vaccination; no cases of hospitalisation after vaccination; no deaths related to the vaccination; no cerebral vein thrombosis cases after vaccination; and no cases of myocarditis were reported, the fund specified.

    "Sputnik V complies with the highest healthcare standards while demonstrating safety and efficacy during vaccination in the UAE. Sputnik V is one of the best COVID vaccines in the world as confirmed by data from Argentina, Serbia, San-Marino, Bahrain, Hungary, Mexico, and other countries. Administering the Russian vaccine helps create durable immunity among the population and provides for lifting the restrictions and returning to normal life", RDIF CEO Kirill Dmitriev said, as quoted in the press release.

    The vaccine was registered in the UAE in January under its emergency use authorisation procedure.

    Sputnik V has been authorised in 67 countries since the drug's registration last August. According to the latest data on post-vaccination infection rates among 3.8 million vaccinated Russians, the vaccine shows 97.6% efficacy against symptomatic COVID-19 cases.

    Tags:
    Russia, Sputnik V, United Arab Emirates, Russian Direct Investment Fund, Russian Direct Investment Fund (RDIF)
    Community standardsDiscussion